Search Results 1041-1050 of 13330 for monoclonal antibody

  1. Kappa and lambda free light chain test - Mayo Clinic

    Antibodies are proteins that help your immune system recognize and fight germs. Along with heavy chains, light chains help form the part of an antibody ...

  2. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

    Clinical Trials · Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis · More about research at ...

  3. A Study Of Glofitamab And Lenalidomide In People With Mantle Cell Lymphoma - Mayo Clinic

    -History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins) -Patient with history ...

  4. Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as rituximab may block tumor growth in different ways by targeting certain cells. LMP-specific T-cells are special immune system ...

  5. A Study Of RBC Antibody Thermal Amplitude Testing For Cardiovascular Surgery - Mayo Clinic

    The purpose of this study is to establish the positive screening rate for 4°C reacting RBC autoantibodies (4°C RBC autoantibody screen) amongst cardiovascular ...

  6. A Study To Investigate Ubamatamab With And Without REGN7075 In Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    Has received prior monoclonal antibody against PD-(L)1 within 21 days of the first dose of study intervention 6. Has had other prior anti-cancer ...

  7. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

    For monoclonal antibody therapy, the subject is < 1 half-life or <4 weeks from the last dose. 7. Chronic, systemically administered glucocorticoids in doses ...

  8. CAR-T Cell Therapy Clinical Trials - Mayo Clinic Research

    ... monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in ...

  9. Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy

    ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...

  10. Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine - Mayo Clinic

    Receipt of any monoclonal antibody treatment (within or outside a clinical trial) within 6 months before screening. Previously dosed with ALD403 or any ...